12 patents
Utility
Reduction of post-surgery cancer metastasis by combination of cannabidiol and NR2F6 inhibition
1 Aug 23
Disclosed are means of stimulating systemic immunity and reduction of post-surgery tumor metastasis through the concurrent intralymphatic inhibition of NR2F6 and treatment with cannabidiol.
Thomas Ichim, David Koos
Filed: 29 Sep 20
Utility
Suppression of pathological angiogenesis by inhibition of NR2F6
23 May 23
Disclosed are means, methods and compositions of matter useful for suppressing pathological production of new blood vessels in conditions such as cancer and wet macular degeneration.
Thomas Ichim, David Koos
Filed: 2 Nov 20
Utility
kn4edi50peddgwis7l5kso0zhzww8e ohhpg4o
15 Sep 22
Disclosed are means, methods and compositions of matter useful for suppressing pathological production of new blood vessels in conditions such as cancer and wet macular degeneration.
Thomas Ichim, David Koos
Filed: 2 Nov 20
Utility
x2snv6vq13a8mbibrfocd5io87mc54hxcwjkxoi43oxzl4yh97wa76jzpwe
8 Feb 22
Disclosed are compounds useful for alteration of NR2F6 activity.
David Koos, Thomas Ichim
Filed: 29 Nov 16
Utility
6lnd3zhfxy76 vygdd6hu53zfffaobvwrjfcfg9l
30 Dec 21
Cancer associated inflammation has been reported to act as an immune suppressive mechanism through augmentation of myeloid suppressor cells, as well as downregulation of T cell receptor (TCR) signaling through the cleavage of the CD3 zeta chain.
Thomas Ichim, David Koos
Filed: 29 Sep 20
Utility
mn3j43mu snqgun39ztye5d9u32xb5a26ge9tsrn
18 Nov 21
Disclosed are means of stimulating systemic immunity and reduction of post-surgery tumor metastasis through the concurrent intralymphatic inhibition of NR2F6 and treatment with cannabidiol.
Thomas Ichim, David Koos
Filed: 29 Sep 20
Utility
ax2db4 jdslia88kguvzvj9
14 Oct 21
Disclosed are compositions of matter, cells, and methodologies for generation of chimeric antigen receptor (CAR) cells with inhibited or absent NR2F6 activity.
Thomas Ichim, David Koos
Filed: 14 Nov 16
Utility
3sdraysnb3lemf7rna2emr448b0je4hsqzrr9j8hzibu1
12 Oct 21
Disclosed are compositions of matters, cells, and treatment protocols useful for induction of anticancer responses in a patient suffering from cancer.
Thomas Ichim, David Koos, Harry Lander
Filed: 21 Apr 17
Utility
ha9ssz0sivt88p63q0ay35lzofzcdanf5
17 Aug 21
Disclosed are antigen specific cancer vaccines in which immunogenic epitopes are produced intracellularly by administration of modified mRNA encoding said immunogenic epitopes.
David Koos, Thomas Ichim
Filed: 23 May 16
Utility
kn8j4jbg3dcnxl2kuhvnl lxzrxccgss5i8croe4q41x2ub
6 Jul 21
Disclosed are means, methods, and compositions of matter useful for generation of cancer inhibitory effector cells producing interleukin-17 (IL-17).
David Koos, Thomas Ichim, Santosh Kesari
Filed: 13 Feb 17
Utility
904jwfykkqfhy9 d0s6j
4 Mar 21
Disclosed are means, methods, and compositions of matter for stimulation of T regulatory (Treg) cells by cannabidiol.
Thomas Ichim, David Koos
Filed: 2 Sep 20
Utility
5s90g15xb2vqh7n0xvk ldnvvpq3
27 Nov 19
Disclosed are compounds useful for alteration of NR2F6 activity.
David KOOS, Thomas ICHIM
Filed: 28 Nov 16
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first